<DOC>
	<DOCNO>NCT01293539</DOCNO>
	<brief_summary>The purpose study show chemotherapy deliver directly artery supply eye ( ophthalmic artery ) patient retinoblastoma safe effective treatment alternative conventional systemic chemotherapy , external beam radiation , surgical removal eye .</brief_summary>
	<brief_title>Intra-arterial Chemotherapy Treatment Intraocular Retinoblastoma</brief_title>
	<detailed_description>Delivering chemotherapeutic agent arterial system ophthalmic artery transforms treatment retinoblastoma systemic chemotherapy local chemotherapy . Administration drug directly target site thus avoids complication adverse event associate toxicity systemic , rather local , chemotherapy .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>Patients newborn 18 year old . Patients intraocular retinoblastoma , unilateral bilateral , would treat either systemic chemotherapy , EBR , enucleation would consider study . Patients age 18 . Patients small , localized intraocular Rb amenable focal therapy ( laser cryotherapy ) . Patients extraocular disease evident MRI ( extension optic nerve ) , massive choroidal/uveal invasion ( grade IIC IID per ARET0332 ) disease outside globe evident MRI physical examination . Documented hypercoagulable disorder vasculopathies . Laboratory exclusion criterion : GFR &lt; 60 mL/min/1.73 m2</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Retinoblastoma</keyword>
	<keyword>intra-arterial chemotherapy</keyword>
	<keyword>angiography</keyword>
</DOC>